Improving pandemic preparedness through advanced biocontainment research
Positioning Mason's Regional Biocontainment Laboratory for Effective Pandemic Preparedness
This study is all about making George Mason University's lab better equipped to handle serious infectious diseases, so researchers can safely and effectively work on new tests, treatments, and vaccines for future health challenges.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Mason University NIH-funded |
| Lab location | 1 site (Fairfax, United States) |
| Project ID | NIH-10910207 on NIH RePORTER |
What this research studies
This research focuses on enhancing the capabilities of George Mason University's Biomedical Laboratory to effectively respond to emerging infectious diseases. It aims to improve the safety and efficiency of research conducted in Biosafety Level 3 (BSL-3) facilities, which are crucial for studying dangerous pathogens. The project will implement upgrades to the laboratory infrastructure, enhance training for personnel, and establish new research cores to facilitate the development of diagnostics, therapeutics, and vaccines. By addressing vulnerabilities exposed during the COVID-19 pandemic, this initiative seeks to create a more robust response framework for future health crises.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals at risk of infectious diseases, particularly during outbreaks.
Not a fit: Patients who are not at risk for infectious diseases or those who do not live in areas affected by pandemics may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved preparedness and response strategies for future pandemics, ultimately saving lives.
How similar studies have performed: Other research initiatives focused on enhancing biocontainment facilities have shown promise in improving pandemic response capabilities, indicating that this approach is both relevant and necessary.
Where this research is happening
Fairfax, United States
- George Mason University — Fairfax, United States (Active)
Researchers
- Principal investigator: Alem, Farhang — George Mason University
- Study coordinator: Alem, Farhang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.